Efficacy of Ertugliflozin on Heart Failure–Related Events in Patients With Type 2 Diabetes Mellitus and Established Atherosclerotic Cardiovascular Disease Results of the VERTIS CV Trial
F Cosentino , CP Cannon , DZI Cherney et al. Keywords:
ertugliflozin;T2DM; ASCVD, HF